These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 6705422)

  • 21. Clearance (née Rowland) concepts: a downdate and an update.
    Benet LZ
    J Pharmacokinet Pharmacodyn; 2010 Dec; 37(6):529-39. PubMed ID: 21113650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A convenient method for estimating the quantity of drug eliminated by the routes other than hepatic metabolism and renal excretion and the fraction of drug that reaches the "first pass" after oral administration.
    Berezhkovskiy LM
    J Pharm Sci; 2006 Apr; 95(4):828-33. PubMed ID: 16489605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics in the elderly.
    Crooks J; O'Malley K; Stevenson IH
    Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of Organ Clearance to Estimation of the In Vivo Hepatic Extraction Ratio.
    Mehvar R
    Curr Clin Pharmacol; 2016; 11(1):47-52. PubMed ID: 26278971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Safe drug prescribing for patients with renal failure].
    Tanaka A; Shimizu H; Matsuo S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():58-66. PubMed ID: 18074518
    [No Abstract]   [Full Text] [Related]  

  • 27. [Kidney and drugs - urinary lithiasis. Pharmacokinetic glossary].
    Balant L
    Rev Med Suisse Romande; 1980 Nov; 100(11):949-56. PubMed ID: 7466067
    [No Abstract]   [Full Text] [Related]  

  • 28. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.
    Rubin GM; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):437-50. PubMed ID: 6527233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramide.
    Giacomini KM; Blaschke TF
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():42-8. PubMed ID: 6705426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Guidelines for drug administration for dialysis patients].
    Nakamoto M
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():80-6. PubMed ID: 15250273
    [No Abstract]   [Full Text] [Related]  

  • 32. Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.
    Vaughan
    Eur J Clin Pharmacol; 1977; 11(1):57-64. PubMed ID: 832659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of plasma protein binding kinetics on hepatic clearance assessed from a "tube" model and a "well-stirred" model.
    Jansen JA
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):15-26. PubMed ID: 7229915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of drug kinetics in blood on the calculation of oral bioavailability in linear pharmacokinetics: the traditional equation may considerably overestimate the true value.
    Berezhkovskiy LM
    J Pharm Sci; 2006 Apr; 95(4):834-48. PubMed ID: 16493592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance.
    Gibaldi M; Koup JR
    Eur J Clin Pharmacol; 1981; 20(4):299-305. PubMed ID: 7308282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic clearance concepts and misconceptions: Why the well-stirred model is still used even though it is not physiologic reality?
    Pang KS; Han YR; Noh K; Lee PI; Rowland M
    Biochem Pharmacol; 2019 Nov; 169():113596. PubMed ID: 31398312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of saturable binding on the pharmacokinetics of drugs: a simulation.
    Oie S; Guentert TW; Tozer TN
    J Pharm Pharmacol; 1980 Jul; 32(7):471-7. PubMed ID: 6105182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-pass elimination. Basic concepts and clinical consequences.
    Pond SM; Tozer TN
    Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics in renal failure.
    Nancarrow C; Mather LE
    Anaesth Intensive Care; 1983 Nov; 11(4):350-60. PubMed ID: 6359952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing pediatric dosing: a developmental pharmacologic approach.
    Anderson GD; Lynn AM
    Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.